Biogen Inc (BIIB)
173.79
-0.21
(-0.12%)
USD |
NASDAQ |
Nov 01, 16:00
175.18
+1.39
(+0.80%)
After-Hours: 20:00
Biogen Shareholders Equity (Quarterly): 16.36B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 16.36B |
June 30, 2024 | 15.89B |
March 31, 2024 | 15.21B |
December 31, 2023 | 14.80B |
September 30, 2023 | 14.48B |
June 30, 2023 | 14.47B |
March 31, 2023 | 13.80B |
December 31, 2022 | 13.40B |
September 30, 2022 | 12.78B |
June 30, 2022 | 11.87B |
March 31, 2022 | 11.24B |
December 31, 2021 | 10.90B |
September 30, 2021 | 10.43B |
June 30, 2021 | 10.75B |
March 31, 2021 | 10.68B |
December 31, 2020 | 10.70B |
September 30, 2020 | 10.76B |
June 30, 2020 | 11.31B |
March 31, 2020 | 12.55B |
December 31, 2019 | 13.34B |
September 30, 2019 | 14.00B |
June 30, 2019 | 12.95B |
March 31, 2019 | 13.83B |
December 31, 2018 | 13.04B |
September 30, 2018 | 13.77B |
Date | Value |
---|---|
June 30, 2018 | 12.26B |
March 31, 2018 | 14.05B |
December 31, 2017 | 12.61B |
September 30, 2017 | 12.86B |
June 30, 2017 | 11.59B |
March 31, 2017 | 11.48B |
December 31, 2016 | 12.14B |
September 30, 2016 | 12.12B |
June 30, 2016 | 11.40B |
March 31, 2016 | 10.33B |
December 31, 2015 | 9.373B |
September 30, 2015 | 10.57B |
June 30, 2015 | 12.57B |
March 31, 2015 | 11.67B |
December 31, 2014 | 10.81B |
September 30, 2014 | 10.43B |
June 30, 2014 | 9.561B |
March 31, 2014 | 9.137B |
December 31, 2013 | 8.620B |
September 30, 2013 | 8.125B |
June 30, 2013 | 7.902B |
March 31, 2013 | 7.339B |
December 31, 2012 | 6.962B |
September 30, 2012 | 6.660B |
June 30, 2012 | 6.268B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
10.43B
Minimum
Sep 2021
16.36B
Maximum
Sep 2024
12.79B
Average
12.66B
Median
Shareholders Equity (Quarterly) Benchmarks
Eli Lilly and Co | 14.24B |
Ionis Pharmaceuticals Inc | 263.70M |
Sage Therapeutics Inc | 551.84M |
Regeneron Pharmaceuticals Inc | 29.33B |
Moderna Inc | 11.71B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 28.31B |
Total Liabilities (Quarterly) | 11.95B |
Debt to Equity Ratio | 0.3847 |
Current Ratio | 1.259 |
Net Debt Paydown Yield | -0.01% |